Beijing Tuo Rui Detection Technology Co., Ltd.
A third-party testing platform for domestic animals and a professional medical testing institution for small domestic animal diagnostic project.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor | €0.0 | round | |
| investor | €0.0 | round | |
$15.8m | Series B | ||
| Total Funding | 000k | ||
Related Content
Established in September 2013, Beijing Tuo Rui Detection Technology Co., Ltd. operates as a third-party testing platform focused on animal medical diagnostics. The company was co-founded by Dr. Zhang Rui, who holds a professional background in immunology and molecular biology. After securing first place in the healthcare category of the Innovation China final competition in 2013, the company was formally established. The firm's legal representative is Zhang Zhong, who also serves as CEO.
The company provides integrated "service + product" solutions to pet hospitals, positioning itself as a comprehensive service platform within the animal medical sector. Its business model is centered on offering professional diagnostic testing services and products to animal hospitals and other end-users. This includes a wide array of testing services such as pathology, microbiology, immunology, and genetic testing. Beijing Tuo Rui Detection Technology also supplies medical equipment and consumables related to diagnostics. The company's laboratory operations are guided by ISO15189 standards, ensuring a comprehensive quality management system.
The company serves the growing pet medical industry by providing scientific and professional support to animal hospitals. Its client base primarily consists of these veterinary care providers. To facilitate its services nationwide, the firm has established a network of regional laboratories, including the North China, East China, and Southwest China detection centers, alongside a research and development center in Hangzhou. Significant milestones include several funding rounds, such as an A round of 10 million RMB in January 2015, and a B+ round of approximately 100 million RMB in March 2018. In 2019, the company received a strategic investment of tens of millions of RMB from a fund associated with Dian Diagnostics, a major medical diagnosis service operator.
Keywords: animal diagnostics, pet medical testing, veterinary laboratory services, third-party animal testing, animal disease detection, pathology services, genetic testing for animals, microbiology testing, immunology testing, pet healthcare solutions, veterinary diagnostic products, animal hospital support, veterinary lab network, animal medical R&D, pet diagnostics China, Zhang Rui, Zhang Zhong, Dian Diagnostics investment